메뉴 건너뛰기




Volumn 68, Issue 4, 2014, Pages 434-443

Biomarkers in atrial fibrillation: An overview

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ANTICOAGULANT AGENT; C REACTIVE PROTEIN; D DIMER; BIOLOGICAL MARKER;

EID: 84897067762     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/ijcp.12304     Document Type: Review
Times cited : (41)

References (99)
  • 1
    • 0025779484 scopus 로고
    • Atrial fibrillation as an independent risk factor for stroke: The Framingham Study
    • Wolf PA, Abbott RD, Kannel WB,. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991; 22 (8): 983-8.
    • (1991) Stroke , vol.22 , Issue.8 , pp. 983-988
    • Wolf, P.A.1    Abbott, R.D.2    Kannel, W.B.3
  • 2
    • 34548455445 scopus 로고    scopus 로고
    • Independent predictors of stroke in patients with atrial fibrillation: A systematic review
    • Stroke Risk in Atrial Fibrilation Working Group
    • Stroke Risk in Atrial Fibrilation Working Group. Independent predictors of stroke in patients with atrial fibrillation: a systematic review. Neurology 2007; 69 (6): 546-54.
    • (2007) Neurology , vol.69 , Issue.6 , pp. 546-554
  • 4
    • 0032480265 scopus 로고    scopus 로고
    • Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins
    • Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339 (10): 659-66.
    • (1998) N Engl J Med , vol.339 , Issue.10 , pp. 659-666
    • Haissaguerre, M.1    Jais, P.2    Shah, D.C.3    Takahashi, A.4    Hocini, M.5    Quiniou, G.6
  • 5
    • 4444299660 scopus 로고    scopus 로고
    • Atrial fibrillation and heart failure: Natural history and pharmacological treatment
    • Savelieva I, John CA,. Atrial fibrillation and heart failure: natural history and pharmacological treatment. Europace 2004; 5 (Suppl. 1): S5-19.
    • (2004) Europace , vol.5 , Issue.SUPPL. 1
    • Savelieva, I.1    John, C.A.2
  • 6
    • 0037032224 scopus 로고    scopus 로고
    • Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women
    • Tsang TS, Gersh BJ, Appleton CP, Tajik AJ, Barnes ME, Bailey KR, et al. Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. J Am Coll Cardiol 2002; 40 (9): 1636-44.
    • (2002) J Am Coll Cardiol , vol.40 , Issue.9 , pp. 1636-1644
    • Tsang, T.S.1    Gersh, B.J.2    Appleton, C.P.3    Tajik, A.J.4    Barnes, M.E.5    Bailey, K.R.6
  • 7
    • 58149204184 scopus 로고    scopus 로고
    • Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
    • Watson T, Shantsila E, Lip GY,. Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited. Lancet 2009; 373 (9658): 155-66.
    • (2009) Lancet , vol.373 , Issue.9658 , pp. 155-166
    • Watson, T.1    Shantsila, E.2    Lip, G.Y.3
  • 8
    • 84870226617 scopus 로고    scopus 로고
    • Inflammation in atrial fibrillation
    • Guo Y, Lip GY, Apostolakis S,. Inflammation in atrial fibrillation. J Am Coll Cardiol 2012; 60 (22): 2263-70.
    • (2012) J Am Coll Cardiol , vol.60 , Issue.22 , pp. 2263-2270
    • Guo, Y.1    Lip, G.Y.2    Apostolakis, S.3
  • 10
    • 77949492717 scopus 로고    scopus 로고
    • Role of inflammation and oxidative stress in atrial fibrillation
    • Li J, Solus J, Chen Q, Rho YH, Milne G, Stein CM, et al. Role of inflammation and oxidative stress in atrial fibrillation. Heart Rhythm 2010; 7 (4): 438-44.
    • (2010) Heart Rhythm , vol.7 , Issue.4 , pp. 438-444
    • Li, J.1    Solus, J.2    Chen, Q.3    Rho, Y.H.4    Milne, G.5    Stein, C.M.6
  • 11
    • 73249149518 scopus 로고    scopus 로고
    • Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: The ATRIA study
    • Singer DE, Chang Y, Fang MC, Borowsky LH, Pomernacki NK, Udaltsova N, et al. Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study. Circ Cardiovasc Qual Outcomes 2009; 2 (4): 297-304.
    • (2009) Circ Cardiovasc Qual Outcomes , vol.2 , Issue.4 , pp. 297-304
    • Singer, D.E.1    Chang, Y.2    Fang, M.C.3    Borowsky, L.H.4    Pomernacki, N.K.5    Udaltsova, N.6
  • 12
    • 0035854054 scopus 로고    scopus 로고
    • Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation
    • Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ,. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001; 285 (22): 2864-70.
    • (2001) JAMA , vol.285 , Issue.22 , pp. 2864-2870
    • Gage, B.F.1    Waterman, A.D.2    Shannon, W.3    Boechler, M.4    Rich, M.W.5    Radford, M.J.6
  • 13
    • 77954392300 scopus 로고    scopus 로고
    • The CHADS2 score for stroke risk stratification in atrial fibrillation-friend or foe?
    • Karthikeyan G, Eikelboom JW,. The CHADS2 score for stroke risk stratification in atrial fibrillation-friend or foe? Thromb Haemost 2010; 104 (1): 45-8.
    • (2010) Thromb Haemost , vol.104 , Issue.1 , pp. 45-48
    • Karthikeyan, G.1    Eikelboom, J.W.2
  • 14
    • 76749163232 scopus 로고    scopus 로고
    • Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The euro heart survey on atrial fibrillation
    • Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ,. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010; 137 (2): 263-72.
    • (2010) Chest , vol.137 , Issue.2 , pp. 263-272
    • Lip, G.Y.1    Nieuwlaat, R.2    Pisters, R.3    Lane, D.A.4    Crijns, H.J.5
  • 15
    • 77957699729 scopus 로고    scopus 로고
    • Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
    • Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 31 (19): 2369-429.
    • (2010) Eur Heart J , vol.31 , Issue.19 , pp. 2369-2429
    • Camm, A.J.1    Kirchhof, P.2    Lip, G.Y.3    Schotten, U.4    Savelieva, I.5    Ernst, S.6
  • 16
    • 84875508668 scopus 로고    scopus 로고
    • 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation - Developed with the special contribution of the European Heart Rhythm Association
    • Camm AJ, Lip GY, De CR, Savelieva I, Atar D, Hohnloser SH, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation-developed with the special contribution of the European Heart Rhythm Association. Europace 2012; 14 (10): 1385-413.
    • (2012) Europace , vol.14 , Issue.10 , pp. 1385-1413
    • Camm, A.J.1    Lip, G.Y.2    De, C.R.3    Savelieva, I.4    Atar, D.5    Hohnloser, S.H.6
  • 17
    • 79551645746 scopus 로고    scopus 로고
    • Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: Nationwide cohort study
    • Olesen JB, Lip GY, Hansen ML, Hansen PR, Tolstrup JS, Lindhardsen J, et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ 2011; 342: d124.
    • (2011) BMJ , vol.342
    • Olesen, J.B.1    Lip, G.Y.2    Hansen, M.L.3    Hansen, P.R.4    Tolstrup, J.S.5    Lindhardsen, J.6
  • 18
    • 84897438891 scopus 로고    scopus 로고
    • Risk stratification of patients with atrial fibrillation: Biomarkers and other future perspectives
    • Providencia R, Paiva L, Barra S,. Risk stratification of patients with atrial fibrillation: biomarkers and other future perspectives. World J Cardiol 2012; 4 (6): 195-200.
    • (2012) World J Cardiol , vol.4 , Issue.6 , pp. 195-200
    • Providencia, R.1    Paiva, L.2    Barra, S.3
  • 19
    • 84862885223 scopus 로고    scopus 로고
    • Predictive value of the CHA2DS2-VASc score in atrial fibrillation patients at high risk for stroke despite oral anticoagulation
    • Jover E, Roldan V, Gallego P, Hernandez-Romero D, Valdes M, Vicente V, et al. Predictive value of the CHA2DS2-VASc score in atrial fibrillation patients at high risk for stroke despite oral anticoagulation. Rev Esp Cardiol (Engl Ed) 2012; 65 (7): 627-33.
    • (2012) Rev Esp Cardiol (Engl Ed) , vol.65 , Issue.7 , pp. 627-633
    • Jover, E.1    Roldan, V.2    Gallego, P.3    Hernandez-Romero, D.4    Valdes, M.5    Vicente, V.6
  • 20
    • 82655172003 scopus 로고    scopus 로고
    • Bleeding risk assessment and management in atrial fibrillation patients. Executive summary of a position document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] working group on thrombosis
    • Lip GY, Andreotti F, Fauchier L, Huber K, Hylek E, Knight E, et al. Bleeding risk assessment and management in atrial fibrillation patients. Executive summary of a position document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] working group on thrombosis. Thromb Haemost 2011; 106 (6): 997-1011.
    • (2011) Thromb Haemost , vol.106 , Issue.6 , pp. 997-1011
    • Lip, G.Y.1    Andreotti, F.2    Fauchier, L.3    Huber, K.4    Hylek, E.5    Knight, E.6
  • 21
    • 77955872745 scopus 로고    scopus 로고
    • A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The Euro Heart Survey
    • Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY,. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 2010; 138 (5): 1093-100.
    • (2010) Chest , vol.138 , Issue.5 , pp. 1093-1100
    • Pisters, R.1    Lane, D.A.2    Nieuwlaat, R.3    De Vos, C.B.4    Crijns, H.J.5    Lip, G.Y.6
  • 22
    • 78650878679 scopus 로고    scopus 로고
    • Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: The HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score
    • Lip GY, Frison L, Halperin JL, Lane DA,. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score. J Am Coll Cardiol 2011; 57 (2): 173-80.
    • (2011) J Am Coll Cardiol , vol.57 , Issue.2 , pp. 173-180
    • Lip, G.Y.1    Frison, L.2    Halperin, J.L.3    Lane, D.A.4
  • 23
    • 84862256342 scopus 로고    scopus 로고
    • Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation
    • Gallego P, Roldan V, Torregrosa JM, Galvez J, Valdes M, Vicente V, et al. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation. Circ Arrhythm Electrophysiol 2012; 5 (2): 312-8.
    • (2012) Circ Arrhythm Electrophysiol , vol.5 , Issue.2 , pp. 312-318
    • Gallego, P.1    Roldan, V.2    Torregrosa, J.M.3    Galvez, J.4    Valdes, M.5    Vicente, V.6
  • 24
    • 78650951581 scopus 로고    scopus 로고
    • A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice
    • van Staa TP, Setakis E, Di Tanna GL, Lane DA, Lip GY,. A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice. J Thromb Haemost 2011; 9 (1): 39-48.
    • (2011) J Thromb Haemost , vol.9 , Issue.1 , pp. 39-48
    • Van Staa, T.P.1    Setakis, E.2    Di Tanna, G.L.3    Lane, D.A.4    Lip, G.Y.5
  • 25
    • 39149084073 scopus 로고    scopus 로고
    • Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation
    • Fang MC, Go AS, Chang Y, Borowsky L, Pomernacki NK, Singer DE,. Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation. J Am Coll Cardiol 2008; 51 (8): 810-5.
    • (2008) J Am Coll Cardiol , vol.51 , Issue.8 , pp. 810-815
    • Fang, M.C.1    Go, A.S.2    Chang, Y.3    Borowsky, L.4    Pomernacki, N.K.5    Singer, D.E.6
  • 26
    • 84859424764 scopus 로고    scopus 로고
    • Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: A Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy
    • Hijazi Z, Oldgren J, Andersson U, Connolly SJ, Ezekowitz MD, Hohnloser SH, et al. Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy. Circulation 2012; 125 (13): 1605-16.
    • (2012) Circulation , vol.125 , Issue.13 , pp. 1605-1616
    • Hijazi, Z.1    Oldgren, J.2    Andersson, U.3    Connolly, S.J.4    Ezekowitz, M.D.5    Hohnloser, S.H.6
  • 28
    • 84878314042 scopus 로고    scopus 로고
    • N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: Insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects with Atrial Fibrillation)
    • Hijazi Z, Wallentin L, Siegbahn A, Andersson U, Christersson C, Ezekowitz J, et al. N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects with Atrial Fibrillation). J Am Coll Cardiol 2013; 61 (22): 2274-84.
    • (2013) J Am Coll Cardiol , vol.61 , Issue.22 , pp. 2274-2284
    • Hijazi, Z.1    Wallentin, L.2    Siegbahn, A.3    Andersson, U.4    Christersson, C.5    Ezekowitz, J.6
  • 29
    • 84865258462 scopus 로고    scopus 로고
    • High sensitivity cardiac troponin T and interleukin-6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation
    • Roldán V, Marin F, Diaz J, Gallego P, Jover E, Romera M, et al. High sensitivity cardiac troponin T and interleukin-6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation. J Thromb Haemost 2012; 10 (8): 1500-7.
    • (2012) J Thromb Haemost , vol.10 , Issue.8 , pp. 1500-1507
    • Roldán, V.1    Marin, F.2    Diaz, J.3    Gallego, P.4    Jover, E.5    Romera, M.6
  • 30
    • 33645300793 scopus 로고    scopus 로고
    • Troponin i as a predictor of coronary heart disease and mortality in 70-year-old men: A community-based cohort study
    • Zethelius B, Johnston N, Venge P,. Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men: a community-based cohort study. Circulation 2006; 113 (8): 1071-8.
    • (2006) Circulation , vol.113 , Issue.8 , pp. 1071-1078
    • Zethelius, B.1    Johnston, N.2    Venge, P.3
  • 32
    • 0041431119 scopus 로고    scopus 로고
    • Cardiac troponin i is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure
    • Horwich TB, Patel J, MacLellan WR, Fonarow GC,. Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation 2003; 108 (7): 833-8.
    • (2003) Circulation , vol.108 , Issue.7 , pp. 833-838
    • Horwich, T.B.1    Patel, J.2    MacLellan, W.R.3    Fonarow, G.C.4
  • 33
    • 79952350346 scopus 로고    scopus 로고
    • Minor elevations in troponin i are associated with mortality and adverse cardiac events in patients with atrial fibrillation
    • van den Bos EJ, Constantinescu AA, van Domburg RT, Akin S, Jordaens LJ, Kofflard MJ,. Minor elevations in troponin I are associated with mortality and adverse cardiac events in patients with atrial fibrillation. Eur Heart J 2011; 32 (5): 611-7.
    • (2011) Eur Heart J , vol.32 , Issue.5 , pp. 611-617
    • Van Den Bos, E.J.1    Constantinescu, A.A.2    Van Domburg, R.T.3    Akin, S.4    Jordaens, L.J.5    Kofflard, M.J.6
  • 34
    • 84878323589 scopus 로고    scopus 로고
    • High sensitivity troponin-T for risk stratification in atrial fibrillation during treatment with apixaban or warfarin
    • Wallentin L, Hijazi Z, Siegbahn A, Schollin M, Alexander JH, Atar D, et al. High sensitivity troponin-T for risk stratification in atrial fibrillation during treatment with apixaban or warfarin. Eur Heart J 2012; 33: (Abstract supplement 53).
    • (2012) Eur Heart J , vol.33
    • Wallentin, L.1    Hijazi, Z.2    Siegbahn, A.3    Schollin, M.4    Alexander, J.H.5    Atar, D.6
  • 36
    • 84859796046 scopus 로고    scopus 로고
    • B-type natriuretic peptide predicts new-onset atrial fibrillation in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention
    • Asanin M, Stankovic S, Mrdovic I, Matic D, Savic L, Majkic-Singh N, et al. B-type natriuretic peptide predicts new-onset atrial fibrillation in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention. Peptides 2012; 35 (1): 74-7.
    • (2012) Peptides , vol.35 , Issue.1 , pp. 74-77
    • Asanin, M.1    Stankovic, S.2    Mrdovic, I.3    Matic, D.4    Savic, L.5    Majkic-Singh, N.6
  • 37
    • 70449337406 scopus 로고    scopus 로고
    • N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: The Cardiovascular Health Study
    • Patton KK, Ellinor PT, Heckbert SR, Christenson RH, DeFilippi C, Gottdiener JS, et al. N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study. Circulation 2009; 120 (18): 1768-74.
    • (2009) Circulation , vol.120 , Issue.18 , pp. 1768-1774
    • Patton, K.K.1    Ellinor, P.T.2    Heckbert, S.R.3    Christenson, R.H.4    Defilippi, C.5    Gottdiener, J.S.6
  • 38
    • 30344466069 scopus 로고    scopus 로고
    • Is atrial fibrillation an inflammatory disorder?
    • Boos CJ, Anderson RA, Lip GY,. Is atrial fibrillation an inflammatory disorder? Eur Heart J 2006; 27 (2): 136-49.
    • (2006) Eur Heart J , vol.27 , Issue.2 , pp. 136-149
    • Boos, C.J.1    Anderson, R.A.2    Lip, G.Y.3
  • 39
    • 59649104145 scopus 로고    scopus 로고
    • The evolving role of C-reactive protein in atherothrombosis
    • Devaraj S, Singh U, Jialal I,. The evolving role of C-reactive protein in atherothrombosis. Clin Chem 2009; 55 (2): 229-38.
    • (2009) Clin Chem , vol.55 , Issue.2 , pp. 229-238
    • Devaraj, S.1    Singh, U.2    Jialal, I.3
  • 41
    • 34247869882 scopus 로고    scopus 로고
    • High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: Relationship to stroke risk factors, stroke risk stratification schema, and prognosis
    • Lip GY, Patel JV, Hughes E, Hart RG,. High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis. Stroke 2007; 38 (4): 1229-37.
    • (2007) Stroke , vol.38 , Issue.4 , pp. 1229-1237
    • Lip, G.Y.1    Patel, J.V.2    Hughes, E.3    Hart, R.G.4
  • 42
    • 84870558451 scopus 로고    scopus 로고
    • Inflammatory biomarkers as risk factors for future atrial fibrillation. An eleven-year follow-up of 6315 men and women: The Tromso study
    • Nyrnes A, Njolstad I, Mathiesen EB, Wilsgaard T, Hansen JB, Skjelbakken T, et al. Inflammatory biomarkers as risk factors for future atrial fibrillation. An eleven-year follow-up of 6315 men and women: the Tromso study. Gend Med 2012; 9 (6): 536-47.
    • (2012) Gend Med , vol.9 , Issue.6 , pp. 536-547
    • Nyrnes, A.1    Njolstad, I.2    Mathiesen, E.B.3    Wilsgaard, T.4    Hansen, J.B.5    Skjelbakken, T.6
  • 43
    • 4644356317 scopus 로고    scopus 로고
    • Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation
    • Conway DS, Buggins P, Hughes E, Lip GY,. Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation. Am Heart J 2004; 148 (3): 462-6.
    • (2004) Am Heart J , vol.148 , Issue.3 , pp. 462-466
    • Conway, D.S.1    Buggins, P.2    Hughes, E.3    Lip, G.Y.4
  • 44
    • 83555176026 scopus 로고    scopus 로고
    • Usefulness of high-sensitivity C-reactive protein to predict mortality in patients with atrial fibrillation (from the Atherosclerosis Risk in Communities [ARIC] Study)
    • Hermida J, Lopez FL, Montes R, Matsushita K, Astor BC, Alonso A,. Usefulness of high-sensitivity C-reactive protein to predict mortality in patients with atrial fibrillation (from the Atherosclerosis Risk In Communities [ARIC] Study). Am J Cardiol 2012; 109 (1): 95-9.
    • (2012) Am J Cardiol , vol.109 , Issue.1 , pp. 95-99
    • Hermida, J.1    Lopez, F.L.2    Montes, R.3    Matsushita, K.4    Astor, B.C.5    Alonso, A.6
  • 45
    • 70350057629 scopus 로고    scopus 로고
    • Activated nuclear factor-kappaB and increased tumor necrosis factor-alpha in atrial tissue of atrial fibrillation
    • Qu YC, Du YM, Wu SL, Chen QX, Wu HL, Zhou SF,. Activated nuclear factor-kappaB and increased tumor necrosis factor-alpha in atrial tissue of atrial fibrillation. Scand Cardiovasc J 2009; 43 (5): 292-7.
    • (2009) Scand Cardiovasc J , vol.43 , Issue.5 , pp. 292-297
    • Qu, Y.C.1    Du, Y.M.2    Wu, S.L.3    Chen, Q.X.4    Wu, H.L.5    Zhou, S.F.6
  • 46
    • 66149189441 scopus 로고    scopus 로고
    • Interleukin-2 as a predictor of early postoperative atrial fibrillation after cardiopulmonary bypass graft (CABG)
    • Hak L, Mysliwska J, Wieckiewicz J, Szyndler K, Siebert J, Rogowski J,. Interleukin-2 as a predictor of early postoperative atrial fibrillation after cardiopulmonary bypass graft (CABG). J Interferon Cytokine Res 2009; 29 (6): 327-32.
    • (2009) J Interferon Cytokine Res , vol.29 , Issue.6 , pp. 327-332
    • Hak, L.1    Mysliwska, J.2    Wieckiewicz, J.3    Szyndler, K.4    Siebert, J.5    Rogowski, J.6
  • 47
  • 48
    • 38349098963 scopus 로고    scopus 로고
    • Interleukin-6 and atrial fibrillation in patients with coronary artery disease: Data from the Heart and Soul Study
    • Marcus GM, Whooley MA, Glidden DV, Pawlikowska L, Zaroff JG, Olgin JE,. Interleukin-6 and atrial fibrillation in patients with coronary artery disease: data from the Heart and Soul Study. Am Heart J 2008; 155 (2): 303-9.
    • (2008) Am Heart J , vol.155 , Issue.2 , pp. 303-309
    • Marcus, G.M.1    Whooley, M.A.2    Glidden, D.V.3    Pawlikowska, L.4    Zaroff, J.G.5    Olgin, J.E.6
  • 51
    • 0042244275 scopus 로고    scopus 로고
    • Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation
    • Roldan V, Marin F, Blann AD, Garcia A, Marco P, Sogorb F, et al. Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation. Eur Heart J 2003; 24 (14): 1373-80.
    • (2003) Eur Heart J , vol.24 , Issue.14 , pp. 1373-1380
    • Roldan, V.1    Marin, F.2    Blann, A.D.3    Garcia, A.4    Marco, P.5    Sogorb, F.6
  • 52
    • 32344453629 scopus 로고    scopus 로고
    • Hypercoagulopathy in stroke patients with nonvalvular atrial fibrillation: Hematologic and cardiologic investigations
    • Turgut N, Akdemir O, Turgut B, Demir M, Ekuklu G, Vural O, et al. Hypercoagulopathy in stroke patients with nonvalvular atrial fibrillation: hematologic and cardiologic investigations. Clin Appl Thromb Hemost 2006; 12 (1): 15-20.
    • (2006) Clin Appl Thromb Hemost , vol.12 , Issue.1 , pp. 15-20
    • Turgut, N.1    Akdemir, O.2    Turgut, B.3    Demir, M.4    Ekuklu, G.5    Vural, O.6
  • 53
    • 0242636998 scopus 로고    scopus 로고
    • Left atrial appendage function and abnormal hypercoagulability in patients with atrial flutter
    • Sakurai K, Hirai T, Nakagawa K, Kameyama T, Nozawa T, Asanoi H, et al. Left atrial appendage function and abnormal hypercoagulability in patients with atrial flutter. Chest 2003; 124 (5): 1670-4.
    • (2003) Chest , vol.124 , Issue.5 , pp. 1670-1674
    • Sakurai, K.1    Hirai, T.2    Nakagawa, K.3    Kameyama, T.4    Nozawa, T.5    Asanoi, H.6
  • 54
    • 0346272855 scopus 로고    scopus 로고
    • High D-dimer levels predict cardiovascular events in patients with chronic atrial fibrillation during oral anticoagulant therapy
    • Vene N, Mavri A, Kosmelj K, Stegnar M,. High D-dimer levels predict cardiovascular events in patients with chronic atrial fibrillation during oral anticoagulant therapy. Thromb Haemost 2003; 90 (6): 1163-72.
    • (2003) Thromb Haemost , vol.90 , Issue.6 , pp. 1163-1172
    • Vene, N.1    Mavri, A.2    Kosmelj, K.3    Stegnar, M.4
  • 55
    • 33645388630 scopus 로고    scopus 로고
    • D-dimer level influences thromboembolic events in patients with atrial fibrillation
    • Nozawa T, Inoue H, Hirai T, Iwasa A, Okumura K, Lee JD, et al. D-dimer level influences thromboembolic events in patients with atrial fibrillation. Int J Cardiol 2006; 109 (1): 59-65.
    • (2006) Int J Cardiol , vol.109 , Issue.1 , pp. 59-65
    • Nozawa, T.1    Inoue, H.2    Hirai, T.3    Iwasa, A.4    Okumura, K.5    Lee, J.D.6
  • 56
    • 79958796133 scopus 로고    scopus 로고
    • Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients
    • Roldan V, Marin F, Muina B, Torregrosa JM, Hernandez-Romero D, Valdes M, et al. Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients. J Am Coll Cardiol 2011; 57 (25): 2496-504.
    • (2011) J Am Coll Cardiol , vol.57 , Issue.25 , pp. 2496-2504
    • Roldan, V.1    Marin, F.2    Muina, B.3    Torregrosa, J.M.4    Hernandez-Romero, D.5    Valdes, M.6
  • 57
    • 77951912589 scopus 로고    scopus 로고
    • Evidence that D-dimer levels predict subsequent thromboembolic and cardiovascular events in patients with atrial fibrillation during oral anticoagulant therapy
    • Sadanaga T, Sadanaga M, Ogawa S,. Evidence that D-dimer levels predict subsequent thromboembolic and cardiovascular events in patients with atrial fibrillation during oral anticoagulant therapy. J Am Coll Cardiol 2010; 55 (20): 2225-31.
    • (2010) J Am Coll Cardiol , vol.55 , Issue.20 , pp. 2225-2231
    • Sadanaga, T.1    Sadanaga, M.2    Ogawa, S.3
  • 58
    • 77955446306 scopus 로고    scopus 로고
    • Usefulness of CHADS2 score to predict C-reactive protein, left atrial blood stasis, and prognosis in patients with nonrheumatic atrial fibrillation
    • Maehama T, Okura H, Imai K, Yamada R, Obase K, Saito K, et al. Usefulness of CHADS2 score to predict C-reactive protein, left atrial blood stasis, and prognosis in patients with nonrheumatic atrial fibrillation. Am J Cardiol 2010; 106 (4): 535-8.
    • (2010) Am J Cardiol , vol.106 , Issue.4 , pp. 535-538
    • Maehama, T.1    Okura, H.2    Imai, K.3    Yamada, R.4    Obase, K.5    Saito, K.6
  • 59
    • 34548749926 scopus 로고    scopus 로고
    • Prediction of left atrial appendage thrombi in non-valvular atrial fibrillation
    • Habara S, Dote K, Kato M, Sasaki S, Goto K, Takemoto H, et al. Prediction of left atrial appendage thrombi in non-valvular atrial fibrillation. Eur Heart J 2007; 28 (18): 2217-22.
    • (2007) Eur Heart J , vol.28 , Issue.18 , pp. 2217-2222
    • Habara, S.1    Dote, K.2    Kato, M.3    Sasaki, S.4    Goto, K.5    Takemoto, H.6
  • 60
    • 35448966162 scopus 로고    scopus 로고
    • Soluble E-selectin, von Willebrand factor, soluble thrombomodulin, and total body nitrate/nitrite product as indices of endothelial damage/dysfunction in paroxysmal, persistent, and permanent atrial fibrillation
    • Freestone B, Chong AY, Nuttall S, Blann AD, Lip GY,. Soluble E-selectin, von Willebrand factor, soluble thrombomodulin, and total body nitrate/nitrite product as indices of endothelial damage/dysfunction in paroxysmal, persistent, and permanent atrial fibrillation. Chest 2007; 132 (4): 1253-8.
    • (2007) Chest , vol.132 , Issue.4 , pp. 1253-1258
    • Freestone, B.1    Chong, A.Y.2    Nuttall, S.3    Blann, A.D.4    Lip, G.Y.5
  • 61
    • 0031803087 scopus 로고    scopus 로고
    • The endothelium in atherothrombotic disease: Assessment of function, mechanisms and clinical implications
    • Blann AD, Lip GY,. The endothelium in atherothrombotic disease: assessment of function, mechanisms and clinical implications. Blood Coagul Fibrinolysis 1998; 9 (4): 297-306.
    • (1998) Blood Coagul Fibrinolysis , vol.9 , Issue.4 , pp. 297-306
    • Blann, A.D.1    Lip, G.Y.2
  • 62
    • 0037044431 scopus 로고    scopus 로고
    • Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation: Relationship to stroke risk factors
    • Conway DS, Pearce LA, Chin BS, Hart RG, Lip GY,. Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors. Circulation 2002; 106 (15): 1962-7.
    • (2002) Circulation , vol.106 , Issue.15 , pp. 1962-1967
    • Conway, D.S.1    Pearce, L.A.2    Chin, B.S.3    Hart, R.G.4    Lip, G.Y.5
  • 63
    • 33748360506 scopus 로고    scopus 로고
    • Additive role of plasma von Willebrand factor levels to clinical factors for risk stratification of patients with atrial fibrillation
    • Lip GY, Lane D, Van WC, Hart RG,. Additive role of plasma von Willebrand factor levels to clinical factors for risk stratification of patients with atrial fibrillation. Stroke 2006; 37 (9): 2294-300.
    • (2006) Stroke , vol.37 , Issue.9 , pp. 2294-2300
    • Lip, G.Y.1    Lane, D.2    Van, W.C.3    Hart, R.G.4
  • 64
    • 36348929899 scopus 로고    scopus 로고
    • Soluble CD40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fibrillation
    • Ferro D, Loffredo L, Polimeni L, Fimognari F, Villari P, Pignatelli P, et al. Soluble CD40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fibrillation. Arterioscler Thromb Vasc Biol 2007; 27 (12): 2763-8.
    • (2007) Arterioscler Thromb Vasc Biol , vol.27 , Issue.12 , pp. 2763-2768
    • Ferro, D.1    Loffredo, L.2    Polimeni, L.3    Fimognari, F.4    Villari, P.5    Pignatelli, P.6
  • 65
    • 33947362451 scopus 로고    scopus 로고
    • Elevated platelet microparticle levels in nonvalvular atrial fibrillation: Relationship to P-selectin and antithrombotic therapy
    • Choudhury A, Chung I, Blann AD, Lip GY,. Elevated platelet microparticle levels in nonvalvular atrial fibrillation: relationship to P-selectin and antithrombotic therapy. Chest 2007; 131 (3): 809-15.
    • (2007) Chest , vol.131 , Issue.3 , pp. 809-815
    • Choudhury, A.1    Chung, I.2    Blann, A.D.3    Lip, G.Y.4
  • 66
    • 0036774388 scopus 로고    scopus 로고
    • A study of platelet activation in paroxysmal, persistent and permanent atrial fibrillation
    • Kamath S, Chin BS, Blann AD, Lip GY,. A study of platelet activation in paroxysmal, persistent and permanent atrial fibrillation. Blood Coagul Fibrinolysis 2002; 13 (7): 627-36.
    • (2002) Blood Coagul Fibrinolysis , vol.13 , Issue.7 , pp. 627-636
    • Kamath, S.1    Chin, B.S.2    Blann, A.D.3    Lip, G.Y.4
  • 67
    • 20244366108 scopus 로고    scopus 로고
    • Digoxin use is associated with increased platelet and endothelial cell activation in patients with nonvalvular atrial fibrillation
    • Chirinos JA, Castrellon A, Zambrano JP, Jimenez JJ, Jy W, Horstman LL, et al. Digoxin use is associated with increased platelet and endothelial cell activation in patients with nonvalvular atrial fibrillation. Heart Rhythm 2005; 2 (5): 525-9.
    • (2005) Heart Rhythm , vol.2 , Issue.5 , pp. 525-529
    • Chirinos, J.A.1    Castrellon, A.2    Zambrano, J.P.3    Jimenez, J.J.4    Jy, W.5    Horstman, L.L.6
  • 68
    • 33747198470 scopus 로고    scopus 로고
    • A longitudinal population-based study of prothrombotic factors in elderly subjects with atrial fibrillation: The Rotterdam Study 1990-1999
    • Heeringa J, Conway DS, van der Kuip DA, Hofman A, Breteler MM, Lip GY, et al. A longitudinal population-based study of prothrombotic factors in elderly subjects with atrial fibrillation: the Rotterdam Study 1990-1999. J Thromb Haemost 2006; 4 (9): 1944-9.
    • (2006) J Thromb Haemost , vol.4 , Issue.9 , pp. 1944-1949
    • Heeringa, J.1    Conway, D.S.2    Van Der Kuip, D.A.3    Hofman, A.4    Breteler, M.M.5    Lip, G.Y.6
  • 69
    • 82355173337 scopus 로고    scopus 로고
    • Platelet activation and induction of tissue factor in acute and chronic atrial fibrillation: Involvement of mononuclear cell-platelet interaction
    • Hayashi M, Takeshita K, Inden Y, Ishii H, Cheng XW, Yamamoto K, et al. Platelet activation and induction of tissue factor in acute and chronic atrial fibrillation: involvement of mononuclear cell-platelet interaction. Thromb Res 2011; 128 (6): e113-8.
    • (2011) Thromb Res , vol.128 , Issue.6
    • Hayashi, M.1    Takeshita, K.2    Inden, Y.3    Ishii, H.4    Cheng, X.W.5    Yamamoto, K.6
  • 70
    • 84856705480 scopus 로고    scopus 로고
    • Circulating microparticles: New insights into the biochemical basis of microparticle release and activity
    • Montoro-Garcia S, Shantsila E, Marin F, Blann A, Lip GY,. Circulating microparticles: new insights into the biochemical basis of microparticle release and activity. Basic Res Cardiol 2011; 106 (6): 911-23.
    • (2011) Basic Res Cardiol , vol.106 , Issue.6 , pp. 911-923
    • Montoro-Garcia, S.1    Shantsila, E.2    Marin, F.3    Blann, A.4    Lip, G.Y.5
  • 71
    • 83555162500 scopus 로고    scopus 로고
    • Plasma resistin, adiponectin, and risk of incident atrial fibrillation: The Framingham Offspring Study
    • Rienstra M, Sun JX, Lubitz SA, Frankel DS, Vasan RS, Levy D, et al. Plasma resistin, adiponectin, and risk of incident atrial fibrillation: the Framingham Offspring Study. Am Heart J 2012; 163 (1): 119-24.
    • (2012) Am Heart J , vol.163 , Issue.1 , pp. 119-124
    • Rienstra, M.1    Sun, J.X.2    Lubitz, S.A.3    Frankel, D.S.4    Vasan, R.S.5    Levy, D.6
  • 72
    • 70349972139 scopus 로고    scopus 로고
    • The role of resistin as a regulator of inflammation: Implications for various human pathologies
    • Filkova M, Haluzik M, Gay S, Senolt L,. The role of resistin as a regulator of inflammation: implications for various human pathologies. Clin Immunol 2009; 133 (2): 157-70.
    • (2009) Clin Immunol , vol.133 , Issue.2 , pp. 157-170
    • Filkova, M.1    Haluzik, M.2    Gay, S.3    Senolt, L.4
  • 73
    • 46749087463 scopus 로고    scopus 로고
    • Signalling mechanisms underlying the metabolic and other effects of adipokines on the heart
    • Karmazyn M, Purdham DM, Rajapurohitam V, Zeidan A,. Signalling mechanisms underlying the metabolic and other effects of adipokines on the heart. Cardiovasc Res 2008; 79 (2): 279-86.
    • (2008) Cardiovasc Res , vol.79 , Issue.2 , pp. 279-286
    • Karmazyn, M.1    Purdham, D.M.2    Rajapurohitam, V.3    Zeidan, A.4
  • 74
    • 46849090339 scopus 로고    scopus 로고
    • Circulating adiponectin levels in patients with atrial fibrillation
    • Shimano M, Shibata R, Tsuji Y, Kamiya H, Uchikawa T, Harata S, et al. Circulating adiponectin levels in patients with atrial fibrillation. Circ J 2008; 72 (7): 1120-4.
    • (2008) Circ J , vol.72 , Issue.7 , pp. 1120-1124
    • Shimano, M.1    Shibata, R.2    Tsuji, Y.3    Kamiya, H.4    Uchikawa, T.5    Harata, S.6
  • 76
    • 44449144512 scopus 로고    scopus 로고
    • Adiponectin isoforms and cardiovascular disease: The epidemiological evidence has just begun
    • Empana JP,. Adiponectin isoforms and cardiovascular disease: the epidemiological evidence has just begun. Eur Heart J 2008; 29 (10): 1221-3.
    • (2008) Eur Heart J , vol.29 , Issue.10 , pp. 1221-1223
    • Empana, J.P.1
  • 77
    • 33748992313 scopus 로고    scopus 로고
    • Adipocytokines: Mediators linking adipose tissue, inflammation and immunity
    • Tilg H, Moschen AR,. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006; 6 (10): 772-83.
    • (2006) Nat Rev Immunol , vol.6 , Issue.10 , pp. 772-783
    • Tilg, H.1    Moschen, A.R.2
  • 79
    • 0036724336 scopus 로고    scopus 로고
    • Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein
    • Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 2002; 51 (9): 2734-41.
    • (2002) Diabetes , vol.51 , Issue.9 , pp. 2734-2741
    • Nishizawa, H.1    Shimomura, I.2    Kishida, K.3    Maeda, N.4    Kuriyama, H.5    Nagaretani, H.6
  • 80
    • 77952988390 scopus 로고    scopus 로고
    • Chronic kidney disease and prevalent atrial fibrillation: The chronic renal insufficiency cohort (CRIC)
    • Soliman EZ, Prineas RJ, Go AS, Xie D, Lash JP, Rahman M, et al. Chronic kidney disease and prevalent atrial fibrillation: the chronic renal insufficiency cohort (CRIC). Am Heart J 2010; 159 (6): 1102-7.
    • (2010) Am Heart J , vol.159 , Issue.6 , pp. 1102-1107
    • Soliman, E.Z.1    Prineas, R.J.2    Go, A.S.3    Xie, D.4    Lash, J.P.5    Rahman, M.6
  • 82
    • 64549104914 scopus 로고    scopus 로고
    • Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: The anticoagulation and risk factors in atrial fibrillation (ATRIA) study
    • Go AS, Fang MC, Udaltsova N, Chang Y, Pomernacki NK, Borowsky L, et al. Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Circulation 2009; 119 (10): 1363-9.
    • (2009) Circulation , vol.119 , Issue.10 , pp. 1363-1369
    • Go, A.S.1    Fang, M.C.2    Udaltsova, N.3    Chang, Y.4    Pomernacki, N.K.5    Borowsky, L.6
  • 83
    • 84875850514 scopus 로고    scopus 로고
    • Renal impairment in a "real-life" cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding)
    • Roldan V, Marin F, Fernandez H, Manzano-Fernandez S, Gallego P, Valdes M, et al. Renal impairment in a "real-life" cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding). Am J Cardiol 2013; 111 (8): 1159-64.
    • (2013) Am J Cardiol , vol.111 , Issue.8 , pp. 1159-1164
    • Roldan, V.1    Marin, F.2    Fernandez, H.3    Manzano-Fernandez, S.4    Gallego, P.5    Valdes, M.6
  • 84
    • 84869100588 scopus 로고    scopus 로고
    • Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: Insights from the ARISTOTLE trial
    • Hohnloser SH, Hijazi Z, Thomas L, Alexander JH, Amerena J, Hanna M, et al. Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial. Eur Heart J 2012; 33 (22): 2821-30.
    • (2012) Eur Heart J , vol.33 , Issue.22 , pp. 2821-2830
    • Hohnloser, S.H.1    Hijazi, Z.2    Thomas, L.3    Alexander, J.H.4    Amerena, J.5    Hanna, M.6
  • 85
    • 79952662118 scopus 로고    scopus 로고
    • Severe renal impairment and stroke prevention in atrial fibrillation: Implications for thromboprophylaxis and bleeding risk
    • Marinigh R, Lane DA, Lip GY,. Severe renal impairment and stroke prevention in atrial fibrillation: implications for thromboprophylaxis and bleeding risk. J Am Coll Cardiol 2011; 57 (12): 1339-48.
    • (2011) J Am Coll Cardiol , vol.57 , Issue.12 , pp. 1339-1348
    • Marinigh, R.1    Lane, D.A.2    Lip, G.Y.3
  • 86
    • 84877062263 scopus 로고    scopus 로고
    • Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?
    • Roldan V, Marin F, Manzano-Fernandez S, Fernandez H, Gallego P, Valdes M, et al. Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation? Thromb Haemost 2013; 109 (5): 956-60.
    • (2013) Thromb Haemost , vol.109 , Issue.5 , pp. 956-960
    • Roldan, V.1    Marin, F.2    Manzano-Fernandez, S.3    Fernandez, H.4    Gallego, P.5    Valdes, M.6
  • 88
    • 0036228259 scopus 로고    scopus 로고
    • Cystatin C: An improved estimator of glomerular filtration rate?
    • Laterza OF, Price CP, Scott MG,. Cystatin C: an improved estimator of glomerular filtration rate? Clin Chem 2002; 48 (5): 699-707.
    • (2002) Clin Chem , vol.48 , Issue.5 , pp. 699-707
    • Laterza, O.F.1    Price, C.P.2    Scott, M.G.3
  • 89
    • 84869878184 scopus 로고    scopus 로고
    • Genetic polymorphisms for estimating risk of atrial fibrillation: A literature-based meta-analysis
    • Smith JG, Almgren P, Engstrom G, Hedblad B, Platonov PG, Newton-Cheh C, et al. Genetic polymorphisms for estimating risk of atrial fibrillation: a literature-based meta-analysis. J Intern Med 2012; 272 (6): 573-82.
    • (2012) J Intern Med , vol.272 , Issue.6 , pp. 573-582
    • Smith, J.G.1    Almgren, P.2    Engstrom, G.3    Hedblad, B.4    Platonov, P.G.5    Newton-Cheh, C.6
  • 90
    • 78249279636 scopus 로고    scopus 로고
    • Genetic polymorphisms and atrial fibrillation: Insights into the prothrombotic state and thromboembolic risk
    • Lopez-Cuenca A, Marin F, Roldan V, Gonzalez-Conejero R, Hernandez-Romero D, Valdes M, et al. Genetic polymorphisms and atrial fibrillation: insights into the prothrombotic state and thromboembolic risk. Ann Med 2010; 42 (8): 562-75.
    • (2010) Ann Med , vol.42 , Issue.8 , pp. 562-575
    • Lopez-Cuenca, A.1    Marin, F.2    Roldan, V.3    Gonzalez-Conejero, R.4    Hernandez-Romero, D.5    Valdes, M.6
  • 91
    • 0033545826 scopus 로고    scopus 로고
    • Association of the alpha-fibrinogen Thr312Ala polymorphism with poststroke mortality in subjects with atrial fibrillation
    • Carter AM, Catto AJ, Grant PJ,. Association of the alpha-fibrinogen Thr312Ala polymorphism with poststroke mortality in subjects with atrial fibrillation. Circulation 1999; 99 (18): 2423-6.
    • (1999) Circulation , vol.99 , Issue.18 , pp. 2423-2426
    • Carter, A.M.1    Catto, A.J.2    Grant, P.J.3
  • 92
    • 0028958305 scopus 로고
    • Fibrinogen and cardiovascular disorders
    • Lip GY,. Fibrinogen and cardiovascular disorders. QJM 1995; 88 (3): 155-65.
    • (1995) QJM , vol.88 , Issue.3 , pp. 155-165
    • Lip, G.Y.1
  • 93
    • 0030116803 scopus 로고    scopus 로고
    • A variant of beta fibrinogen is a genetic risk factor for coronary artery disease and myocardial infarction
    • Yu Q, Safavi F, Roberts R, Marian AJ,. A variant of beta fibrinogen is a genetic risk factor for coronary artery disease and myocardial infarction. J Investig Med 1996; 44 (4): 154-9.
    • (1996) J Investig Med , vol.44 , Issue.4 , pp. 154-159
    • Yu, Q.1    Safavi, F.2    Roberts, R.3    Marian, A.J.4
  • 94
    • 77954346236 scopus 로고    scopus 로고
    • The association of beta-fibrinogen 455 G/A gene polymorphism with left atrial thrombus and severe spontaneous echo contrast in atrial fibrillation
    • Bozdemir V, Kirimli O, Akdeniz B, Ulgenalp A, Aslan A, Kala V, et al. The association of beta-fibrinogen 455 G/A gene polymorphism with left atrial thrombus and severe spontaneous echo contrast in atrial fibrillation. Anadolu Kardiyol Derg 2010; 10 (3): 209-15.
    • (2010) Anadolu Kardiyol Derg , vol.10 , Issue.3 , pp. 209-215
    • Bozdemir, V.1    Kirimli, O.2    Akdeniz, B.3    Ulgenalp, A.4    Aslan, A.5    Kala, V.6
  • 95
    • 4444378715 scopus 로고    scopus 로고
    • Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation
    • Marin F, Corral J, Roldan V, Gonzalez-Conejero R, del Rey ML, Sogorb F, et al. Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation. J Mol Cell Cardiol 2004; 37 (3): 699-704.
    • (2004) J Mol Cell Cardiol , vol.37 , Issue.3 , pp. 699-704
    • Marin, F.1    Corral, J.2    Roldan, V.3    Gonzalez-Conejero, R.4    Del Rey, M.L.5    Sogorb, F.6
  • 96
    • 52949137889 scopus 로고    scopus 로고
    • Factor VII -323 decanucleotide D/I polymorphism in atrial fibrillation: Implications for the prothrombotic state and stroke risk
    • Roldan V, Marin F, Gonzalez-Conejero R, Garcia-Honrubia A, Marti S, Alfaro A, et al. Factor VII -323 decanucleotide D/I polymorphism in atrial fibrillation: implications for the prothrombotic state and stroke risk. Ann Med 2008; 40 (7): 553-9.
    • (2008) Ann Med , vol.40 , Issue.7 , pp. 553-559
    • Roldan, V.1    Marin, F.2    Gonzalez-Conejero, R.3    Garcia-Honrubia, A.4    Marti, S.5    Alfaro, A.6
  • 97
    • 0033026573 scopus 로고    scopus 로고
    • Role of the 807 C/T polymorphism of the alpha2 gene in platelet GP Ia collagen receptor expression and function - Effect in thromboembolic diseases
    • Corral J, Gonzalez-Conejero R, Rivera J, Ortuno F, Aparicio P, Vicente V,. Role of the 807 C/T polymorphism of the alpha2 gene in platelet GP Ia collagen receptor expression and function-effect in thromboembolic diseases. Thromb Haemost 1999; 81 (6): 951-6.
    • (1999) Thromb Haemost , vol.81 , Issue.6 , pp. 951-956
    • Corral, J.1    Gonzalez-Conejero, R.2    Rivera, J.3    Ortuno, F.4    Aparicio, P.5    Vicente, V.6
  • 98
    • 0034687438 scopus 로고    scopus 로고
    • Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease
    • Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L,. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. N Engl J Med 2000; 343 (16): 1139-47.
    • (2000) N Engl J Med , vol.343 , Issue.16 , pp. 1139-1147
    • Lindahl, B.1    Toss, H.2    Siegbahn, A.3    Venge, P.4    Wallentin, L.5
  • 99
    • 36248975985 scopus 로고    scopus 로고
    • A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: Implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels
    • Tello-Montoliu A, Marin F, Roldan V, Mainar L, Lopez MT, Sogorb F, et al. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels. J Intern Med 2007; 262 (6): 651-8.
    • (2007) J Intern Med , vol.262 , Issue.6 , pp. 651-658
    • Tello-Montoliu, A.1    Marin, F.2    Roldan, V.3    Mainar, L.4    Lopez, M.T.5    Sogorb, F.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.